Bruce E. Maryanoff

An Overview of the Preclinical Aspects of Topiramate: Pharmacology, Pharmacokinetics, and Mechanism of Action

Richard P. Shank, Joseph F. Gardocki, Anthony J. Streeter et al. · Epilepsia · 2000 · 808 citations

Topiramate: Preclinical Evaluation of a Structurally Novel Anticonvulsant

Richard P. Shank, Joseph F. Gardocki, Jeffry L. Vaught et al. · Epilepsia · 1994 · 346 citations

Neurophysiology, Medicine, Preclinical Evaluation +15

Topiramate as an Inhibitor of Carbonic Anhydrase Isoenzymes

Susanna J. Dodgson, Richard P. Shank, Bruce E. Maryanoff · Epilepsia · 2000 · 317 citations

Selective deoxygenation of ketones and aldehydes including hindered systems with sodium cyanoborohydride

Robert O. Hutchins, Cynthia A. Milewski, Bruce E. Maryanoff · Journal of the American Chemical Society · 1973 · 211 citations

Bioorganic Chemistry, Sodium Cyanoborohydride, Engineering +17

Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor

Patricia Andrade‐Gordon, Bruce E. Maryanoff, Claudia K. Derian et al. · Proceedings of the National Academy of Sciences · 1999 · 186 citations · Full text

Tethered-ligand Receptor, Peptide Engineering, Chemical Biology +17